CXCR2 and colorectal carcinoma: In our most recent investigations, we assessed the diagnostic and prognostic significance of the receptor of CXCL1 (CXCR2) as well as its ligand (CXCL8) in CRC patients using the enzyme-linked immunosorbent assay (ELISA) method [28,29].